Exane Derivatives’s Trupanion TRUP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,126
Closed -$100K 944
2022
Q1
$100K Buy
+1,126
New +$104K 0.03% 473
2021
Q4
Sell
-1,760
Closed -$137K 995
2021
Q3
$137K Sell
1,760
-290
-14% -$28.6K 0.03% 483
2021
Q2
$223K Sell
2,050
-652
-24% -$56.7K 0.05% 369
2021
Q1
$206K Sell
2,702
-1,164
-30% -$119K 0.06% 293
2020
Q4
$463K Buy
+3,866
New +$365K 0.14% 174

Other funds holding TRUP

Exane Derivatives's TRUP Position: Q2 2022 in Review

Exane Derivatives sold out of Trupanion (TRUP) in Q2 2022, closing a stake of 1,126 shares — an estimated $100K sold.

Exane Derivatives first reported a position in TRUP in Q4 2020 and held it in 5 quarters. The position peaked at $463K in Q4 2020. 209 funds tracked by Wall St. Rank hold TRUP as of Q2 2022.

  • Exane Derivatives reported no remaining Trupanion position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 1,126 Trupanion shares in Q2 2022, an estimated $100K.
  • Exane Derivatives first reported a position in Trupanion in Q4 2020 and held it in 5 quarters.
  • Exane Derivatives's Trupanion position peaked at $463K in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Trupanion as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.